Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Maasho

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Immunology|May 1, 1994
High serum-soluble interleukin-2 receptor is not associated with the immunosuppression in diffuse cutaneous leishmaniasisH Akuffo, K Maasho
Clinical and Experimental Immunology|December 1, 1993
Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cellsH Akuffo, K Maasho, R Howe
Scandinavian Journal of Immunology. Supplement|January 1, 1992
Cells from healthy non-exposed individuals produce cytokines to selected fractions of Leishmania promastigotesK Maasho, H O Akuffo
Scandinavian Journal of Immunology|March 20, 2004
Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donorsS Nylén, K Maasho, D McMahon-Pratt, et al.
Clinical and Experimental Immunology|February 28, 2003
Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gammaS Nylén, K Maasho, K Söderstrom, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1995
In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testingH Akuffo, M Darce, K Maasho, et al.
Clinical and Experimental Immunology|September 1, 1999
Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cellsH Akuffo, A Alexis, L Eidsmo, et al.
Lancet (London, England)|November 10, 1998
Skin rash for 15 yearsS Montelius, K Maasho, F Pratlong, et al.
Infection and Immunity|May 29, 1998
Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicityK Maasho, F Sanchez, E Schurr, et al.
Clinical and Experimental Immunology|February 1, 1996
Ivermectin-induced immunopotentiation in onchocerciasis: recognition of selected antigens following a single dose of ivermectinH Akuffo, K Maasho, C Lavebratt, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Immunology|May 1, 1994
High serum-soluble interleukin-2 receptor is not associated with the immunosuppression in diffuse cutaneous leishmaniasisH Akuffo, K Maasho
Clinical and Experimental Immunology|December 1, 1993
Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cellsH Akuffo, K Maasho, R Howe
Scandinavian Journal of Immunology. Supplement|January 1, 1992
Cells from healthy non-exposed individuals produce cytokines to selected fractions of Leishmania promastigotesK Maasho, H O Akuffo
Scandinavian Journal of Immunology|March 20, 2004
Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donorsS Nylén, K Maasho, D McMahon-Pratt, et al.
Clinical and Experimental Immunology|February 28, 2003
Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gammaS Nylén, K Maasho, K Söderstrom, et al.
The American Journal of Tropical Medicine and Hygiene|July 1, 1995
In vivo evaluation of immune responses in leishmaniasis: the use of cross-species leishmanin preparations for skin testingH Akuffo, M Darce, K Maasho, et al.
Clinical and Experimental Immunology|September 1, 1999
Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cellsH Akuffo, A Alexis, L Eidsmo, et al.
Lancet (London, England)|November 10, 1998
Skin rash for 15 yearsS Montelius, K Maasho, F Pratlong, et al.
Infection and Immunity|May 29, 1998
Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicityK Maasho, F Sanchez, E Schurr, et al.
Clinical and Experimental Immunology|February 1, 1996
Ivermectin-induced immunopotentiation in onchocerciasis: recognition of selected antigens following a single dose of ivermectinH Akuffo, K Maasho, C Lavebratt, et al.
Pageof 2